This site is intended for healthcare professionals only
LoginRegister
Antibiotics use in children below 2 years tied to reduced vaccine response: StudyAntibiotics use in children below 2 years tied to reduced vaccine response: Study
NTAGI panel recommends Sputnik V first dose as precautionary doseNTAGI panel recommends Sputnik V first dose as precautionary dose
USFDA VRBPA committee to review Novavax COVID vaccineUSFDA VRBPA committee to review Novavax COVID vaccine
COVID-19: WHO backed vaccine resolution wins 24 percent support at ModernaCOVID-19: WHO backed vaccine resolution wins 24 percent support at Moderna
SII Covovax inclusion in vaccination drive for 12-17 age group recommended by NTAGI panelSII Covovax inclusion in vaccination drive for 12-17 age group recommended by NTAGI panel
Govt to soon decrease gap between 2nd dose of Covid vaccine and booster dose to 6 monthsGovt to soon decrease gap between 2nd dose of Covid vaccine and booster dose to 6 months
Moderna seeks USFDA emergency use nod for COVID vaccine in children younger than 6Moderna seeks USFDA emergency use nod for COVID vaccine in children younger than 6
COVID-19 vaccination reduces infection, hospitalization and mortality in heart transplant recipients: JAMACOVID-19 vaccination reduces infection, hospitalization and mortality in heart transplant...
Pfizer seeks USFDA emergency use nod for COVID booster in children aged 5 through 11 yearsPfizer seeks USFDA emergency use nod for COVID booster in children aged 5 through 11 years
Maternal administration of RSVpreF Vaccine Prevents RSV Infection in Infants: NEJMMaternal administration of RSVpreF Vaccine Prevents RSV Infection in Infants: NEJM
DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for childrenDCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for children
Coronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age group of childrenCoronavirus vaccine: DCGI grants emergency use nod to Covaxin, Corbevax, ZycovD for different age...
X